The US Food and Drug Administration (FDA) has approved a new weight loss drug called Zepbound to treat moderate-to-severe obstructive sleep apnea. Zepbound is administered via injection every two weeks and works by reducing hunger and increasing feelings of fullness, helping patients maintain a healthy weight. The approval marks a significant development in the treatment of sleep apnea, which affects an estimated 22 million Americans. With this new medication option, more individuals with obstructive sleep apnea may be able to achieve better sleep quality and overall health.
Source: https://abcnews.go.com/GMA/Wellness/video/fda-approves-weight-loss-drug-zepbound-treat-sleep-117027845